DexCom, Inc. (DXCM)
91.04
-1.30
(-1.41%)
USD |
NASDAQ |
Aug 24, 16:00
91.52
+0.48
(+0.53%)
After-Hours: 20:00
DexCom Debt to Equity Ratio : 0.5335 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5335 |
| March 31, 2026 | 0.4683 |
| December 31, 2025 | 0.5061 |
| September 30, 2025 | 0.9448 |
| June 30, 2025 | 1.002 |
| March 31, 2025 | 1.140 |
| December 31, 2024 | 1.231 |
| September 30, 2024 | 1.309 |
| June 30, 2024 | 1.066 |
| March 31, 2024 | 1.153 |
| December 31, 2023 | 1.254 |
| September 30, 2023 | 1.199 |
| June 30, 2023 | 1.605 |
| March 31, 2023 | 0.9596 |
| December 31, 2022 | 1.006 |
| September 30, 2022 | 1.169 |
| June 30, 2022 | 0.9475 |
| March 31, 2022 | 0.9783 |
| December 31, 2021 | 1.057 |
| September 30, 2021 | 0.8817 |
| June 30, 2021 | 0.9481 |
| March 31, 2021 | 0.9839 |
| December 31, 2020 | 1.007 |
| September 30, 2020 | 1.213 |
| June 30, 2020 | 1.301 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.261 |
| December 31, 2019 | 1.314 |
| September 30, 2019 | 1.453 |
| June 30, 2019 | 1.599 |
| March 31, 2019 | 1.614 |
| December 31, 2018 | 1.534 |
| September 30, 2018 | 0.6156 |
| June 30, 2018 | 0.71 |
| March 31, 2018 | 0.8032 |
| December 31, 2017 | 0.7971 |
| September 30, 2017 | 0.8612 |
| June 30, 2017 | 0.9251 |
| March 31, 2017 | 0.2941 |
| December 31, 2016 | 0.0211 |
| September 30, 2016 | 0.0229 |
| June 30, 2016 | 0.0244 |
| March 31, 2016 | 0.0074 |
| December 31, 2015 | 0.0104 |
| September 30, 2015 | 0.015 |
| June 30, 2015 | 0.0205 |
| March 31, 2015 | 0.0276 |
| December 31, 2014 | 0.0328 |
| September 30, 2014 | 0.0452 |
| June 30, 2014 | 0.0582 |
| March 31, 2014 | 0.07 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| Insulet Corp. | 0.6669 |
| Baxter International, Inc. | 1.427 |
| Globus Medical, Inc. | 0.0235 |
| Stryker Corp. | 0.6439 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.455B |
| Total Liabilities (Quarterly) | 3.834B |
| Shareholders Equity (Quarterly) | 2.621B |
| Current Ratio | 1.733 |
| Net Debt Paydown Yield | 0.93% |